Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City

PLoS One. 2012;7(9):e45141. doi: 10.1371/journal.pone.0045141. Epub 2012 Sep 20.

Abstract

Background: We performed this study 1) to determine the prevalence of community-associated extended spectrum beta-lactamase producing Enterobacteriaceae (ESBLPE) colonization and infection in New York City (NYC); 2) to determine the prevalence of newly-acquired ESBLPE during travel; 3) to look for similarities in contemporaneous hospital-associated bloodstream ESBLPE and travel-associated ESBLPE.

Methods: Subjects were recruited from a travel medicine practice and consented to submit pre- and post-travel stools, which were assessed for the presence of ESBLPE. Pre-travel stools and stools submitted for culture were used to estimate the prevalence of community-associated ESBLPE. The prevalence of ESBLPE-associated urinary tract infections was calculated from available retrospective data. Hospital-associated ESBLPE were acquired from saved bloodstream isolates. All ESBLPE underwent multilocus sequence typing (MLST) and ESBL characterization.

Results: One of 60 (1.7%) pre- or non-travel associated stool was colonized with ESBLPE. Among community-associated urine specimens, 1.3% of Escherichia coli and 1.4% of Klebsiella pneumoniae were identified as ESBLPE. Seven of 28 travelers (25.0%) acquired a new ESBLPE during travel. No similarities were found between travel-associated ESBLPE and hospital-associated ESBLPE. A range of imported ESBL genes were found, including CTX-M-14 and CTX-15.

Conclusion: ESBL colonization and infection were relatively low during the study period in NYC. A significant minority of travelers acquired new ESBLPE during travel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enterobacteriaceae / enzymology*
  • Escherichia coli / enzymology
  • Humans
  • Internationality*
  • New York City / epidemiology
  • Prevalence
  • Residence Characteristics
  • Travel*
  • Urinary Tract Infections / epidemiology
  • Urinary Tract Infections / microbiology
  • beta-Lactamases / biosynthesis*

Substances

  • beta-Lactamases

Grants and funding

Merck provided funding for an Investigator Initiated Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck was allowed to see a copy of the manuscript prior to submissions (with no edits). Merck has agreed to pay the submission fee as per the Grant contract.